Arab World vs Iceland: Access to anti-retroviral drugs, male
Arab World
49.3%
in 2024
Iceland
89.0%
in 2024
Arab World rank
16th
Iceland rank
17th
Access to anti-retroviral drugs, male over time
- Arab World
- Iceland
How they compare
Iceland currently reports 89.0% against 49.3% in Arab World, a difference of 39.7%.
That makes Iceland's figure about 1.8 times Arab World's.
Across all 25 years both countries report, Iceland has been ahead every year.
Arab World ranks 16th and Iceland ranks 17th of 19 groups.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Arab World | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.9% | 45.3% | 38.4% | Iceland |
| 2010s | 24.3% | 68.6% | 44.3% | Iceland |
| 2020s | 44.2% | 86.4% | 42.2% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Arab World or Iceland?
- Iceland, at 89.0% against 49.3% in Arab World as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Arab World and Iceland?
- 39.7%, with Iceland ahead.
- How many years of comparable data are there for Arab World and Iceland?
- 25 years are reported by both, from 2000 to 2024.
- How do Arab World and Iceland rank globally for access to anti-retroviral drugs, male?
- Arab World ranks 16th and Iceland ranks 17th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.